FDA Halts Clinical Trials: Americans’ Cells Exported to Hostile Countries for Genetic Engineering

Learn about the recent FDA decision halting new clinical trials that involve exporting Americans' cells to foreign labs in hostile countries for genetic engineering. This video discusses the implications of this regulatory action on healthcare research ethics, especially for Pharma students interested in understanding the complexities of conducting trials in international settings.
Video Credit to -Ivan_Samkov.mp4

Видео FDA Halts Clinical Trials: Americans’ Cells Exported to Hostile Countries for Genetic Engineering канала MCQ Pedia